PAF-receptor is preferentially expressed in a distinct synthetic phenotype of smooth muscle cells cloned from human internal thoracic artery: Functional implications in cell migration

Biochemical and Biophysical Research Communications

Volumn 346, Issue 3, 2006, Pages 693-699

  Stengel, Dominique ^a   O'Neil, Caroline ^b   Brochériou, Isabelle ^a,c   Karabina, Sonia Athina ^a   Durand, Hervé ^a   Caplice, Noel M ^b   Pickering, J Geoffrey ^d   Ninio, Ewa ^a  

^a INSERM   (France)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d MAYO CLINIC   (United States)

Author keywords

Atherosclerosis; Cell migration; Inflammation; PAF receptor

Indexed keywords

MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ADULTHOOD; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CHEMOTAXIS; CIRCULATION; CONTROLLED STUDY; FUNCTION TEST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; INTERNAL MAMMARY ARTERY; MOLECULAR CLONING; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; STEM CELL;

CELL MOVEMENT; CLONE CELLS; GENE EXPRESSION REGULATION; HUMANS; MAMMARY ARTERIES; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 33745478355     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.05.210     Document Type: Article

References (27)

1. Mueller H.W., Haught C.A., Mcnatt J.M., Cui K.X., Gaskell S.J., Johnston D.A., and Willerson J.T. Measurement of platelet-activating factor in a canine model of coronary thrombosis and in endarterectomy samples from patients with advanced coronary artery disease. Circ. Res. 77 (1995) 54-63
2. Dentan C., Lesnik P., Chapman M.J., and Ninio E. Phagocytic activation induces formation of platelet-activating factor in human monocyte-derived macrophages and in macrophage-derived foam cells. Relevance to the inflammatory reaction in atherogenesis. Eur. J. Biochem. 236 (1996) 48-55
3. Watson A.D., Navab M., Hama S.Y., Sevanian A., Prescott S.M., Stafforini D.M., McIntyre T.M., Du B.N., Fogelman A.M., and Berliner J.A. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J. Clin. Invest. 95 (1995) 774-782
4. Tsoukatos D.C., Arborati M., Liapikos T., Clay K.L., Murphy R.C., Chapman M.J., and Ninio E. Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 3505-3512
5. Honda Z.I., Nakamura M., Miki I., Minami M., Watanabe T., Seyama Y., Okado H., Toh H., Ito K., Miyamoto T., and Shimizu T. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature 349 (1991) 342-346
6. Stengel D., Antonucci M., Arborati M., Hourton D., Griglio S., Chapman M.J., and Ninio E. Expression of the PAF receptor in human monocyte-derived macrophages is down-regulated by oxidized low-density lipoprotein: relevance to the inflammatory phase of atherogenesis. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 954-962
7. Brocheriou I., Stengel D., Mattsson-Hulten L., Stankova J., Rola-Pleszczynski M., Koskas F., Wiklund O., Le Charpentier Y., and Ninio E. Expression of platelet-activating factor receptor in human carotid atherosclerotic plaques: relevance to progression of atherosclerosis. Circulation 102 (2000) 2569-2575
8. Babaev V.R., Bobryshev Y.V., Stenina O.V., Tararak E.M., and Gabbiani G. Heterogeneity of smooth muscle cells in atheromatous plaque of human aorta. Am. J. Pathol. 136 (1990) 1031-1042
9. Ko Y.S., Yeh H.I., Haw M., Dupont E., Kaba R., Plenz G., Robenek H., and Severs N.J. Differential expression of connexin43 and desmin defines two subpopulations of medial smooth muscle cells in the human internal mammary artery. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 1669-1680
10. Wohrley J.D., Frid M.G., Moiseeva E.P., Orton E.C., Belknap J.K., and Stenmark K.R. Hypoxia selectively induces proliferation in a specific subpopulation of smooth muscle cells in the bovine neonatal pulmonary arterial media. J. Clin. Invest. 96 (1995) 273-281
11. Li S., Fan Y.S., Chow L.H., Van Den Diepstraten C., van Der Veer E., Sims S.M., and Pickering J.G. Innate diversity of adult human arterial smooth muscle cells: cloning of distinct subtypes from the internal thoracic artery. Circ. Res. 89 (2001) 517-525
12. Li S., Sims S., Jiao Y., Chow L.H., and Pickering J.G. Evidence from a novel human cell clone that adult vascular smooth muscle cells can convert reversibly between noncontractile and contractile phenotypes. Circ. Res. 85 (1999) 338-348
13. Han C.I., Campbell G.R., and Campbell J.H. Circulating bone marrow cells can contribute to neointimal formation. J. Vasc. Res. 38 (2001) 113-119
14. Sata M., Saiura A., Kunisato A., Tojo A., Okada S., Tokuhisa T., Hirai H., Makuuchi M., Hirata Y., and Nagai R. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med. 8 (2002) 403-409
15. Schober A., Knarren S., Lietz M., Lin E.A., and Weber C. Crucial role of stromal cell-derived factor-1alpha in neointima formation after vascular injury in apolipoprotein E-deficient mice. Circulation 108 (2003) 2491-2497
16. Simper D., Stalboerger P.G., Panetta C.J., Wang S., and Caplice N.M. Smooth muscle progenitor cells in human blood. Circulation 106 (2002) 1199-1204
17. Herbert J.M., Fraisse L., Bachy A., Valette G., Savi P., Laplace M.C., Lassalle J., Roche B., Lale A., and Keane P.E. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist. J. Lipid Mediat. 8 (1993) 31-51
18. Casals-Stenzel J., and Weber K.H. Triazolodiazepines: dissociation of their Paf (platelet activating factor) antagonistic and CNS activity. Br. J. Pharmacol. 90 (1987) 139-146
19. Argmann C.A., Sawyez C.G., Li S., Nong Z., Hegele R.A., Pickering J.G., and Huff M.W. Human smooth muscle cell subpopulations differentially accumulate cholesteryl ester when exposed to native and oxidized lipoproteins. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1290-1296
20. Li S., Chow L.H., and Pickering J.G. Cell surface-bound collagenase-1 and focal substrate degradation stimulate the rear release of motile vascular smooth muscle cells. J. Biol. Chem. 275 (2000) 35384-35392
21. Li J., Han X., Jiang J., Zhong R., Williams G.M., Pickering J.G., and Chow L.H. Vascular smooth muscle cells of recipient origin mediate intimal expansion after aortic allotransplantation in mice. Am. J. Pathol. 158 (2001) 1943-1947
22. Lee C., Sigari F., Segrado T., Horkko S., Hama S., Subbaiah P.V., Miwa M., Navab M., Witztum J.L., and Reaven P.D. All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 1437-1446
23. Baggiolini M., Dewald B., and Thelen M. Effects of PAF on neutrophils and mononuclear phagocytes. Prog. Biochem. Pharmacol. 22 (1988) 90-105
24. Watson A.D., Leitinger N., Navab M., Faull K.F., Horkko S., Witztum J.L., Palinski W., Schwenke D., Salomon R.G., Sha W., Subbanagounder G., Fogelman A.M., and Berliner J.A. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 272 (1997) 13597-13607
25. Pegorier S., Stengel D., Durand H., Croset M., and Ninio E. Oxidized phospholipid: POVPC binds to platelet-activating-factor receptor on human macrophages Implications in atherosclerosis. Atherosclerosis (2005) [ahead on line]
26. Raines E.W. PDGF and cardiovascular disease. Cytokine Growth Factor Rev. 15 (2004) 237-254
27. Yoshida T., and Owens G.K. Molecular determinants of vascular smooth muscle cell diversity. Circ. Res. 96 (2005) 280-291